National Center for Research Resources

National Center for Research Resources
Name	National Center for Research Resources
Type	U.S. federal agency (former)
Formed	1990
Dissolved	2011
Superseding	National Center for Advancing Translational Sciences
Jurisdiction	United States
Headquarters	Bethesda, Maryland

Contents

National Center for Research Resources was a component of the National Institutes of Health that supported biomedical research infrastructure across the United States. It funded clinical and animal research facilities, core laboratories, and shared resources to enable studies by investigators affiliated with institutions such as Harvard Medical School, Johns Hopkins University, Mayo Clinic, and University of California, San Francisco. The center operated programs that interacted with federal entities like the National Science Foundation, the Department of Health and Human Services, and the Veterans Health Administration.

History

The center originated from organizational changes within the National Institutes of Health during the late 20th century when policymakers associated with the Health Research Extension Act debates and leaders from the Office of the Surgeon General sought expanded infrastructure support. Early antecedents included programs administered by the National Institute of General Medical Sciences and legislative initiatives championed by members of the United States Congress such as committees chaired during hearings by representatives from the House Committee on Energy and Commerce and senators aligned with the Senate Committee on Appropriations. Throughout the 1990s and 2000s the center collaborated with institutions like Massachusetts General Hospital, Stanford University School of Medicine, and Yale School of Medicine to develop resources for clinical research networks and animal model repositories. In 2011 its functions were realigned under the newly created National Center for Advancing Translational Sciences following recommendations from advisory groups including panels convened by the Institute of Medicine.

The center’s mission focused on enhancing research capacity at academic and nonprofit institutions such as Columbia University, University of Pennsylvania, Duke University, University of Michigan, and University of Chicago. It provided support for biomedical core facilities, clinical research centers, and comparative medicine programs that served investigators connected to organizations like Children's Hospital Boston, Cleveland Clinic, Emory University School of Medicine, and University of Texas Southwestern Medical Center. Key functions included managing cooperative agreements with networks such as the Clinical and Translational Science Awards predecessor efforts, maintaining repositories akin to those at the Jackson Laboratory, and coordinating resource sharing modeled after programs at the Broad Institute and the Salk Institute for Biological Studies.

Programs administered or funded by the center included clinical research infrastructure similar to the General Clinical Research Centers program, the Reserve/Resource Research Program analogs, and animal resource centers comparable to repositories at the National Primate Research Centers and the American Type Culture Collection. Facilities supported ranged from core laboratories at institutions like University of California, Los Angeles, Northwestern University, Ohio State University, and University of Washington to consortium projects with the Howard Hughes Medical Institute and networks involving the Centers for Disease Control and Prevention. Grant mechanisms enabled shared instrumentation grants resembling those used by investigators at Scripps Research Institute, Fred Hutchinson Cancer Research Center, and Rockefeller University.

The center was organized into divisions and program offices that interacted with directors and senior staff appointed from academic centers including Beth Israel Deaconess Medical Center and Georgetown University Medical Center. Oversight and guidance came from advisory groups with members drawn from institutions like Princeton University, Cornell University, Boston University, and Brown University. Directors liaised with NIH leadership such as the Director of the National Institutes of Health and coordinated with federal partners at the Food and Drug Administration and the Environmental Protection Agency on translational research priorities. Leadership transitions often reflected input from stakeholders including representatives of the American Association for the Advancement of Science and the Association of American Medical Colleges.

Funding streams were appropriated through Congressional action involving the United States Congress and allocated via NIH budget processes similar to those overseen by the Office of Management and Budget. Grant awards supported investigators at centers of excellence including University of North Carolina at Chapel Hill, Penn State University, Vanderbilt University Medical Center, and University of Illinois Chicago. Mechanisms included cooperative agreements, supplements, and shared instrumentation awards used by research groups at Kansas University Medical Center and University of Colorado Anschutz Medical Campus. The center administered multi-year funding that enabled collaborations across networks such as partnerships seen with the Robert Wood Johnson Foundation and foundations like the Gordon and Betty Moore Foundation.

The center’s investments bolstered infrastructure that underpinned discoveries at institutions including Cold Spring Harbor Laboratory, Mount Sinai School of Medicine, Weill Cornell Medicine, and Icahn School of Medicine at Mount Sinai. Its legacy persisted through successor initiatives at the National Center for Advancing Translational Sciences and through infrastructure maintained at research hubs such as the National Primate Research Centers and core facilities patterned after those at the Broad Institute. Alumni of center-supported programs moved to leadership roles at organizations like Biogen, Pfizer, Merck & Co., and policy groups such as the Kaiser Family Foundation, extending the center’s influence across biomedical research, clinical translation, and institutional capacity building.